PDCD1 and head and neck squamous cell carcinoma: Yu et al. found that PD-1 expression increased in samples from patients with HNSCC, in comparison with normal oral mucosa samples (13), which implied that the PD-1 blockade should be more effective at boosting the antitumor immune response in HNSCC.